Tata India Pharma & Healthcare Fund - Growth - Direct Plan

Other Plans and Options
  • 0.7 %Nav, as on 21-05-2025

  • Previous Nav

  • Net Change on 21-05-2025

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Direct Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

Investment objective of the scheme is to provide long term capital appreciation by investing predominantly in equity/equity related instruments of the companies in the Pharma&Healthcare sectors in India. However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved. The Scheme does not assure or guarantee any returns.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
Tata India Pharma & Healthcare Fund-Direct Plan-Growth 1.68 5.48 17.20 24.13 23.74 13.94
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A
NIFTY PHARMA - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
Tata India Pharma & Healthcare Fund-Direct Plan-Growth Dec 28, 2015 17.20 24.13 23.74 0.67 1,222.72
Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option - Growth Jan 01, 2013 15.11 23.09 23.25 0.89 8,259.60
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan - Cumulative Option Jul 13, 2018 23.83 27.93 26.59 1.07 5,295.32
SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH Jan 01, 2013 21.22 27.22 25.81 0.90 3,670.62
DSP Healthcare Fund - Direct Plan - Growth Nov 30, 2018 14.73 23.97 25.46 0.62 2,912.01
Mirae Asset Healthcare Fund Direct Growth Jul 02, 2018 19.10 22.25 24.08 0.50 2,682.70

Fund Holdings as on 30-April-2025

  • SUN PHARMACEUTICAL INDUSTRIES LTD

  • CASH / NET CURRENT ASSET

  • CIPLA LTD

  • AUROBINDO PHARMA LTD

  • APOLLO HOSPITALS ENTERPRISE LTD

  • DIVI LABORATORIES LTD

  • LUPIN LTD

  • FORTIS HEALTHCARE LTD

  • ASTER DM HEALTHCARE LTD

  • ALKEM LABORATORIES LTD

  • HEALTHCARE GLOBAL ENTERPRISES LTD

  • DR REDDYS LABORATORIES LTD

  • WOCKHARDT LTD

  • LAURUS LABS LTD

  • AJANTA PHARMA LTD

  • TORRENT PHARMACEUTICALS LTD

  • METROPOLIS HEALTHCARE LTD

  • KRISHNA INSTITUTE OF MEDICAL SCIENCES LTD

  • DR. LAL PATH LABS LTD

  • IPCA LABORATORIES LTD

  • FDC LTD

  • MEDI ASSIST HEALTHCARE SERVICES LTD

  • DR. AGARWALS HEALTH CARE LTD

  • JUPITER LIFE LINE HOSPITALS LTD

  • INDOCO REMEDIES LTD

  • AKUMS DRUGS AND PHARMACEUTICALS LTD

  • COROMANDEL INTERNATIONAL LTD

  • ZYDUS LIFESCIENCES LTD

  • SANOFI INDIA LTD

  • AMI ORGANICS LTD

  • MANKIND PHARMA LTD

  • MEDPLUS HEALTH SERVICES LTD

  • SANOFI CONSUMER HEALTHCARE INDIA LTD

  • ORCHID PHARMA LTD

  • PROCTER & GAMBLE HEALTH LTD

  • GLAXOSMITHKLINE PHARMACEUTICALS LTD

  • SYNGENE INTERNATIONAL LTD

  • INVENTURUS KNOWLEDGE SOLUTIONS LTD

  • DEEPAK NITRITE LTD

  • A) REPO

  • LAXMI DENTAL LTD

View More

  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Miscellaneous

  • Business Support

  • Fertilizers

  • BPO/ITeS

  • Chemicals

  • Medical Equipment/Supplies/Accessories

View More

  • Cash

  • Equity

View More

About Tata India Pharma & Healthcare Fund

Scheme Analysis

Tata India Pharma & Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to Tata Mutual Fund. It was launched on 28-Dec-2015 and currently has an AUM of ₹1,222.72 crore. Tata India Pharma & Healthcare Fund is benchmarked against NIFTY 50 - TRI as primary index and NIFTY PHARMA - TRI as secondary index.

The NAV of Tata India Pharma & Healthcare Fund ended up ₹0.24(0.7%)yesterday to ₹34.3353.

Among its top 3 holdings the fund has exposure to SUN PHARMACEUTICAL INDUSTRIES LTD, and

The Tata India Pharma & Healthcare Fund is managed by Meeta Shetty and Rajat Srivastava.

Fund House Contact

1903, B Wing, Parinee Crescenzo, G Block, Bandra Kurla Complex, Bandra East, Mumbai - 400 051

022 6282 7777
service@tataamc.com
+91 (22) 22613782